Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections-Reference-Cited by-同舟云学术

Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections

Published:2017 Issue:23 Volume:56 Page:3189-3192
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tsukagoshi Setsuki¹,Ishizawa Kunihiko¹,Hirayanagi Kimitoshi¹,Nagamine Shun¹,Makioka Kouki¹,Fujita Yukio¹,Ikeda Yoshio¹

Affiliation:

1. Department of Neurology, Gunma University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/23/56_8826-17/_pdf

Reference15 articles.

1. 1. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 17: 1411-1413, 1988.

2. 2. Araz N, Okan V, Demirci M, Araz M. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases. Tohoku J Exp Med 211: 285-290, 2007.

3. 3. Pigrau C, Pahissa A, Gropper S, Sureda D, Martinez Vazquez JM. Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 15: 165, 1989.

4. 4. Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D, Peterson PK. Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 34: 1146-1149, 1990.

5. 5. Bickford CL, Spencer AP. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Pharmacotherapy 25: 1389-1395, 2005.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review;Oxford Medical Case Reports;2024-06-01

2. Hepatobiliary calculi associated with ceftriaxone treatment: An analysis of FAERS data from 2004 to 2021;Journal of Infection and Chemotherapy;2023-02

3. Risk Factors for Ceftriaxone-Associated Pseudolithiasis in Adults;Digestion;2023

4. Cefazolin sodium pentahydrate cause urolithiasis: a case report and literature review;Journal of Surgical Case Reports;2022-04-01

5. Rapid onset of ceftriaxone-induced cholelithiasis in an adult patient;Journal of Global Infectious Diseases;2022